ImageneBio (IMA) Form 3: No Shares Reported, Late Filing 08/15/2025

ImageneBio, Inc. director Jonathan Jian Wang submitted an initial Form 3 reporting no securities beneficially owned as of the event date 07/25/2025.

Rhea-AI Filing Summary

ImageneBio, Inc. director Jonathan Jian Wang submitted an initial Form 3 reporting no securities beneficially owned as of the event date 07/25/2025. The filing notes it was submitted late because the reporting person experienced delays obtaining EDGAR access codes; the form is signed by an attorney-in-fact on 08/15/2025. No non-derivative or derivative holdings are disclosed.

Positive

• None.

Negative

• Late filing due to delays obtaining EDGAR access codes, signed 08/15/2025

Insights

Compliance Counsel

Director filed an initial Form 3 reporting zero holdings and a late submission due to EDGAR access delays.

This Form 3 explicitly states no securities are beneficially owned by the reporting director as of the event date 07/25/2025, so there is no disclosed change in ownership to affect shareholder stakes.

The filing also records a late submission attributed to delays obtaining EDGAR codes and is signed on 08/15/2025; this documents a procedural lapse but contains no other compliance violations or corrective actions disclosed in the filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Jonathan Jian Wang report on Form 3 for ImageneBio (IMA)?

The filing states no securities are beneficially owned by Jonathan Jian Wang as of 07/25/2025.

Was the Form 3 filed on time for ImageneBio (IMA)?

No; the Form 3 notes it was filed late due to delays obtaining the reporting person's EDGAR codes and is signed on 08/15/2025.

Does the Form 3 disclose any derivative holdings for the reporting person?

No; Table I and Table II contain no reported non-derivative or derivative securities.

Who signed the Form 3 for the reporting person?

The Form 3 is signed by /s/ Jotin Marango, Attorney-in-Fact on 08/15/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/15/2025 - 04:49 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Jonathan Jian

(Last) (First) (Middle)

C/O IMAGENEBIO, INC.

12526 HIGH BLUFF DRIVE

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/25/2025

3. Issuer Name and Ticker or Trading Symbol
ImageneBio, Inc. [ IMA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney. This Form 3 is being filed late due to delays in obtaining the reporting person's EDGAR codes.

No securities are beneficially owned.

	/s/ Jotin Marango, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.